GlassScriptPhysician profile
Marina M Marvin
NPI 1689316937
$1,241.67
in general payments reported to CMS, 2019-2025
18 companies · $798 in 2025
The $798 reported for 2025 was more than what 81% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $237 · 2024: $207 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147 · Education: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.67 |
| Education | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $267.38 | 2025 | Datroway, Enhertu |
| Novartis Pharmaceuticals Corporation | $137.56 | 2024-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $125.38 | 2023 | Imbruvica |
| Astrazeneca Pharmaceuticals LP | $115.68 | 2023-2025 | Enhertu, Imfinzi |
| Seagen INC. | $95.00 | 2025 | |
| Genentech USA, INC. | $90.84 | 2024-2025 | Itovebi, Polivy, Alecensa |
| Pfizer INC. | $78.39 | 2025 | |
| Janssen Biotech, INC. | $73.12 | 2025 | Rybrevant, Akeega, Erleada |
| Tempus Ai, INC | $47.37 | 2024-2025 | Xt Cdx |
| Tersera Therapeutics LLC | $32.63 | 2025 | Zoladex |
| Eisai INC. | $30.18 | 2025 | |
| Abbvie INC. | $27.40 | 2025 | |
| Celgene Corporation | $27.17 | 2025 | Opdivo |
| Beigene USA, INC. | $26.66 | 2024 | Brukinsa |
| Gilead Sciences, INC. | $18.61 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $17.05 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $15.90 | 2025 | Lynparza, Keytruda, Keytruda Qlex |
| Cumberland Pharmaceuticals, INC. | $15.35 | 2025 | Sancuso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Marvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.